共 67 条
[1]
Findlay JM(2015)Cerebral vasospasm: a review Can J Neurol Sci 43 15-32
[2]
Nisar J(2011)Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the neurocritical care society’s multidisciplinary consensus conference Neurocrit Care 15 211-240
[3]
Darsaut T(2019)Medical treatment failure for symptomatic vasospasm after subarachnoid hemorrhage threatens long-term outcome Stroke 50 1696-1702
[4]
Diringer MN(1991)Fatal rupture of the intracranial carotid artery during transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage Case report J Neurosurg 74 985-990
[5]
Bleck TP(2018)Milrinone-associated cardiomyopathy and arrhythmia in cerebral vasospasm World Neurosurg 114 252-256
[6]
Hemphill JC(2008)Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): Randomized, double-blind, placebo-controlled phase 2 dose-finding trial Stroke 39 3015-3021
[7]
Suwatcharangkoon S(2011)Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2) Lancet Neurol 10 618-625
[8]
De Marchis GM(2009)Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke 40 1963-1968
[9]
Witsch J(2017)Ganglion blocks as a treatment of pain: current perspectives J Pain Res 10 2815-2826
[10]
Linskey ME(2011)Stellate ganglion block for treatment of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage - a preliminary study J Anaesthesiol Clin Pharmacol 27 516-521